From: Radiofrequency ablation for pediatric recurrent hepatocellular carcinoma: a single-center experience
Characteristics | n = 10 |
---|---|
Age (year) * | 11.7 ± 4 (6–17) |
Gender (Male/Female) | 9/1 |
Purpose of RFA (Curative/Palliative) | 7/3 |
Hepatitis infection (Yes/No) | 8/2 |
Cirrhosis (Yes/No) | 6/4 |
Primary treatment (Resection/Transplantation) | 8/2 |
Child-Pugh grade (A/B) | 9/1 |
ALBI grade (1/2/3) | 6/3/1 |
ECOG PS score (0/1) | 7/3 |
Biochemical examinations | Â |
AFP (ug/L) | 7961 (2.8-50260) |
 ALT (IU/L) | 39.1 ± 19 (11–71) |
 ALB (g/L) | 38.9 ± 7.4 (20-45.1) |
 TBIL (µmol/L) | 10 ± 3.5 (6.3–16.7) |
 PT (s) | 12.5 ± 1.4 (10.2–15.3) |
 WBC account (×109/L) | 5.11 ± 2 (3–10) |
 PLT account (×109/L) | 152.6 ± 82 (18–306) |
Tumor number (Solitary/Multiple) | 5/5 |